Sanara MedTech Inc. - 8-K Filing
Sanara MedTech Inc. reported first-quarter net revenue of $27.8 million on May 11, 2026, a 19% increase from $23.4 million in the same period last year. The company achieved GAAP net income from continuing operations of $0.4 million or $0.04 per diluted share compared to a loss of $0.6 million or $0.07 per diluted share in Q1 2025, driven by higher sales and improved gross margins.
Tickers: $SMTI